| Mahjabeen Haq, DO | |
|
585 Broadway, Massapequa, NY 11758-5023 | |
| (516) 797-1234 | |
| Not Available |
| Full Name | Mahjabeen Haq |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Rheumatology |
| Location | 585 Broadway, Massapequa, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790123289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 2835691 (New York) | Primary |
| Entity Name | Internal Medicine Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619188489 PECOS PAC ID: 1951291467 Enrollment ID: O20110711000004 |
News Archive
A multi-institutional study involving Massachusetts General Hospital (MGH) researchers has identified a chromosomal abnormality that appears to increase susceptibility to autism.
Oramed Pharmaceuticals Inc., a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement with sanofi-aventis. According to the MSA, sanofi-aventis will supply Oramed with specified quantities of recombinant human insulin to be used by Oramed for its clinical trials in the USA.
Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.
Avraham Pharmaceuticals Ltd. announced today the commencement of a Phase 2 clinical trial to evaluate the safety and efficacy of ladostigil in patients diagnosed with mild cognitive impairment.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."
› Verified 4 days ago
| Entity Name | Liraoc Rheumatology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346437100 PECOS PAC ID: 3072836709 Enrollment ID: O20150102001108 |
News Archive
A multi-institutional study involving Massachusetts General Hospital (MGH) researchers has identified a chromosomal abnormality that appears to increase susceptibility to autism.
Oramed Pharmaceuticals Inc., a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement with sanofi-aventis. According to the MSA, sanofi-aventis will supply Oramed with specified quantities of recombinant human insulin to be used by Oramed for its clinical trials in the USA.
Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.
Avraham Pharmaceuticals Ltd. announced today the commencement of a Phase 2 clinical trial to evaluate the safety and efficacy of ladostigil in patients diagnosed with mild cognitive impairment.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mahjabeen Haq, DO 25 Beaumont Dr, Plainview, NY 11803-2507 Ph: (455) 361-0578 | Mahjabeen Haq, DO 585 Broadway, Massapequa, NY 11758-5023 Ph: (516) 797-1234 |
News Archive
A multi-institutional study involving Massachusetts General Hospital (MGH) researchers has identified a chromosomal abnormality that appears to increase susceptibility to autism.
Oramed Pharmaceuticals Inc., a developer of oral delivery systems, today announced that Oramed entered into a Manufacturing Supply Agreement with sanofi-aventis. According to the MSA, sanofi-aventis will supply Oramed with specified quantities of recombinant human insulin to be used by Oramed for its clinical trials in the USA.
Urban epidemics resulting from viral diseases, such as West Nile fever and chikungunya fever, are transmitted by infected mosquitoes.
Avraham Pharmaceuticals Ltd. announced today the commencement of a Phase 2 clinical trial to evaluate the safety and efficacy of ladostigil in patients diagnosed with mild cognitive impairment.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."
› Verified 4 days ago
Dr. Roger Kersten, D.O. Rheumatology Medicare: Medicare Enrolled Practice Location: 510 Hicksville Rd, Massapequa, NY 11758 Phone: 516-795-2626 Fax: 516-799-7451 | |
Miloni H Thakker, Rheumatology Medicare: Medicare Enrolled Practice Location: 1061 N Broadway Ste 2, Massapequa, NY 11758 Phone: 631-758-7003 | |
David Alan Goldstein, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 510 Hicksville Road, Massapequa, NY 11758 Phone: 516-795-2626 Fax: 516-799-7451 | |
Dr. Grigoriy Krichmar, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 510 Hicksville Rd, Massapequa, NY 11758 Phone: 516-795-2626 Fax: 516-799-7451 | |
Michael Falkove, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 4150 Sunrise Hwy, Massapequa, NY 11758 Phone: 516-541-1721 Fax: 516-541-1463 | |
Dr. Conan Tu, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4150 Sunrise Hwy, Massapequa, NY 11758 Phone: 516-541-1721 Fax: 516-541-1463 | |
Dr. Herbert I. Pasternak, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 187 Veterans Blvd, Massapequa, NY 11758 Phone: 516-795-5523 Fax: 516-795-5521 |